Glaxo shares hit six-year high on raised full-year earnings guidance
Having hit a six-year high prior to its midday third-quarter results, shares in pharmaceutical giant GlaxoSmithkine (GSK) pared their earlier gains but still traded up 1.4% to £17.65 after it beat expectations and upgraded its full...
30 October 2019